Zobrazeno 1 - 3
of 3
pro vyhledávání: '"I. R. Melamed"'
Publikováno v:
Clinical and Experimental Immunology. 184:228-236
Summary This open-label multi-centre study evaluated Gammaplex® 5%, a human intravenous immunoglobulin (IVIG) 5% liquid, in 25 children and adolescent patients (aged 3–16 years) with primary immunodeficiency diseases (PIDs). Subjects received Gamm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c19948e41e73f06fe50d66a2569960e5
https://doi.org/10.1111/cei.12760
https://doi.org/10.1111/cei.12760
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 13
To assess the effect of erythropoietin (EPO) treatment on blood pressure in continuous ambulatory peritoneal dialysis (CAPD) patients, we analyzed in a retrospective study the results of 6 months of EPO treatment in 17 CAPD patients. There were 10 fe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fd48491a1ae2c832df14bd716985566d
https://pubmed.ncbi.nlm.nih.gov/8399663
https://pubmed.ncbi.nlm.nih.gov/8399663
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 13
Seventeen patients--10 females, 7 males--mean age 52 years (range: 21-77 years), on CAPD for an average of 35 months (range 10-160 months) were studied. Mean initial dose of EPO was 114 +/- 45 U/kg/week subcutaneously (range: 59-209). The dose was ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::570c09a782dd38a4c9e94e7e4ec93705
https://pubmed.ncbi.nlm.nih.gov/8399661
https://pubmed.ncbi.nlm.nih.gov/8399661